13F HOLDINGS REPORT
KVP Capital Advisors, LP
Quarter ended Q4 2025 · Filed February 18, 2026 · Accession 0001104659-26-016901
Total Value
$103.3M
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | TERN | 440,000 | $17.8M | 17.20% |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 42,900 | $12.6M | 12.24% |
| 3 | AXSOME THERAPEUTICS INC | AXSM | 36,200 | $6.6M | 6.40% |
| 4 | JAZZ PHARMACEUTICALS PLC | JAZZ | 31,000 | $5.3M | 5.10% |
| 5 | WHITEHAWK THERAPEUTICS INC | WHWK | 2,165,997 | $5.2M | 5.07% |
| 6 | TREVI THERAPEUTICS INC | TRVI | 414,000 | $5.2M | 5.02% |
| 7 | INSMED INC | INSM | 28,497 | $5.0M | 4.80% |
| 8 | PROTAGONIST THERAPEUTICS INC | PTGX | 53,000 | $4.6M | 4.48% |
| 9 | DISC MEDICINE INC | IRON | 58,250 | $4.6M | 4.48% |
| 10 | MBX BIOSCIENCES INC | MBX | 121,524 | $3.8M | 3.71% |
| 11 | SAVARA INC | SVRA | 605,280 | $3.6M | 3.53% |
| 12 | TRAVERE THERAPEUTICS INC | TVTX | 91,000 | $3.5M | 3.36% |
| 13 | EDGEWISE THERAPEUTICS INC | EWTX | 133,000 | $3.3M | 3.19% |
| 14 | JAZZ PHARMACEUTICALS PLC | JAZZ | 17,500 | $3.0M | 2.88% |
| 15 | SOLENO THERAPEUTICS INC | SLNO | 59,700 | $2.8M | 2.67% |
| 16 | UNITED THERAPEUTICS CORP DEL | UTHR | 4,750 | $2.3M | 2.24% |
| 17 | ACHIEVE LIFE SCIENCES INC | ACHV | 462,355 | $2.3M | 2.22% |
| 18 | REVOLUTION MEDICINES INC | RVMDW | 27,500 | $2.2M | 2.12% |
| 19 | SCHOLAR ROCK HLDG CORP | SRRK | 45,000 | $2.0M | 1.92% |
| 20 | VERA THERAPEUTICS INC | VERA | 32,700 | $1.7M | 1.60% |
| 21 | FULCRUM THERAPEUTICS INC | FULC | 110,900 | $1.3M | 1.21% |
| 22 | IMMIX BIOPHARMA INC | IMMX | 230,423 | $1.2M | 1.17% |
| 23 | NEKTAR THERAPEUTICS | NKTR | 26,900 | $1.1M | 1.10% |
| 24 | CABALETTA BIO INC | CABA | 505,431 | $1.1M | 1.07% |
| 25 | FULCRUM THERAPEUTICS INC | FULC | 50,000 | $565,500 | 0.55% |
| 26 | CELCUITY INC | CELC | 4,000 | $398,960 | 0.39% |
| 27 | VYNE THERAPEUTICS INC | VYNE | 500,551 | $290,370 | 0.28% |